James Pursley, President of Hinge Health, Inc. (NYSE:HNGE), filed a Form 4 on September 23, 2026, disclosing the sale of 33,000 shares of Class A Common Stock on September 21, 2026, pursuant to a pre-established Rule 10b5-1 trading plan.
Key Highlights
- Three sell transactions on one day: Pursley disposed of 9,065 shares, 23,135 shares, and 800 shares of Class A Common Stock, all on September 21, 2026.
- Weighted average prices: The three tranches were sold at weighted average prices of $93.368, $94.4044, and $95.0968 per share, respectively.
- Rule 10b5-1 plan: All sales were effected pursuant to a Rule 10b5-1 trading plan adopted by Pursley on June 12, 2026.
- Remaining ownership: Following the transactions, Pursley directly held 666,909 shares of Class A Common Stock, according to the filing.
- Transaction code: All three transactions carried code "S" (open-market sale), with direct ownership form.
Details of James Pursley's Class A Common Stock Sales at Hinge Health
According to the Form 4 filed with the SEC on September 23, 2026, James Pursley, serving as President of Hinge Health, Inc., disposed of a combined 33,000 shares of Class A Common Stock in three separate transactions on September 21, 2026. The filing indicates all sales were made under a Rule 10b5-1 trading plan that Pursley adopted on June 12, 2026.
The first transaction involved the disposal of 9,065 shares at a weighted average price of $93.368, with the actual per-share prices ranging from a low of $92.93 to a high of $93.92, as noted in the filing. The second transaction covered 23,135 shares at a weighted average of $94.4044, with the price range spanning $93.93 to $94.92. The third and smallest tranche comprised 800 shares sold at a weighted average of $95.0968, with individual prices between $94.94 and $95.51. The filing states that Pursley will provide full information on the number of shares sold at each separate price within each range upon request to SEC staff, the issuer, or stockholders.
After the three disposals, the filing reports that Pursley directly held 666,909 shares of Class A Common Stock. No derivative securities transactions were reported in Table II of the filing. The Form 4 was signed by James Budge as Attorney-in-Fact on September 23, 2026, and the filing notes that a checkbox indicates the transactions were made pursuant to a contract, instruction, or written plan satisfying the affirmative defense conditions of Rule 10b5-1(c).
What Was Disclosed
The filing reports three open-market sales of Hinge Health Class A Common Stock by the company's President on September 21, 2026, totaling 33,000 shares across three price tranches, all executed under a pre-established Rule 10b5-1 plan.




Please wait processing your request...